STREAMEX CORP. (STEX) Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -98.65M USD | Operating Income (Loss) |
| Revenue | (m) | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | (m) | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-98.65M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $-103.86M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $-71.09M | (m) | (m) | $31.00K | (m) | (m) |
| 2025-09-30 | $-30.64M | (m) | (m) | $127.00K | (m) | (m) |
| 2025-06-30 | $-27.48M | (m) | (m) | $277.00K | (m) | (m) |
| 2025-03-31 | $-12.41M | (m) | (m) | $600.00K | (m) | (m) |
| 2024-12-31 | $-12.86M | $40.00K | (m) | $832.00K | (m) | -32155.00% |
| 2024-09-30 | $-17.85M | $39.00K | (m) | $1.91M | (m) | -45758.97% |
| 2024-06-30 | $-18.95M | $40.00K | (m) | $2.90M | (m) | -47367.50% |
| 2024-03-31 | $-24.56M | $27.00K | (m) | $4.27M | (m) | -90974.07% |
| 2023-12-31 | $-28.51M | $18.00K | (m) | $5.09M | (m) | -158400.00% |
| 2023-09-30 | $-29.34M | $141.00K | (m) | $5.04M | (m) | -20810.64% |
| 2023-06-30 | $-31.78M | $275.00K | (m) | $5.62M | (m) | -11555.64% |
| 2023-03-31 | $-26.59M | $283.00K | (m) | $5.27M | (m) | -9394.35% |
| 2022-12-31 | $-27.27M | $286.00K | $57.00K | $5.82M | (m) | -9533.22% |
| 2022-09-30 | $-29.27M | $159.00K | $30.00K | $6.05M | (m) | -18406.29% |
| 2022-06-30 | $-30.58M | $132.00K | $38.00K | $5.64M | (m) | -23167.42% |
| 2022-03-31 | $-32.92M | $331.00K | $100.00K | $5.95M | (m) | -9944.41% |
| 2021-12-31 | $-33.41M | $441.00K | $199.00K | $5.60M | (m) | -7576.19% |
| 2021-09-30 | $-35.34M | (m) | (m) | $6.83M | (m) | (m) |
| 2021-06-30 | $-40.64M | (m) | (m) | $10.42M | (m) | (m) |
| 2021-03-31 | $-54.94M | (m) | (m) | $14.47M | (m) | (m) |
| 2020-12-31 | $-59.18M | (m) | (m) | $18.14M | (m) | (m) |
| 2020-09-30 | $-63.49M | (m) | (m) | $20.34M | (m) | (m) |
| 2020-06-30 | $-55.89M | (m) | (m) | $17.08M | (m) | (m) |
| 2020-03-31 | $-41.53M | (m) | (m) | $13.18M | (m) | (m) |
| 2019-12-31 | $-34.60M | (m) | (m) | $9.74M | (m) | (m) |
| 2019-09-30 | $-10.45M | (m) | (m) | $2.76M | (m) | (m) |
| 2019-06-30 | $-8.10M | (m) | (m) | $1.86M | (m) | (m) |
| 2019-03-31 | $-5.88M | (m) | (m) | $1.49M | (m) | (m) |
| 2018-12-31 | $-17.26M | (m) | (m) | $4.37M | (m) | (m) |
| 2018-09-30 | $-16.63M | (m) | (m) | $4.01M | (m) | (m) |
| 2018-06-30 | $-15.39M | (m) | (m) | $4.39M | (m) | (m) |
| 2018-03-31 | $-12.64M | (m) | (m) | $4.28M | (m) | (m) |
| 2017-12-31 | $-12.91M | (m) | (m) | $4.76M | (m) | (m) |
| 2017-09-30 | $-9.59M | (m) | (m) | $4.32M | (m) | (m) |
| 2017-06-30 | $-9.23M | (m) | (m) | $3.75M | (m) | (m) |
| 2017-03-31 | $-11.75M | (m) | (m) | $3.62M | (m) | (m) |
| 2016-12-31 | $-11.16M | (m) | (m) | $2.65M | (m) | (m) |
| 2016-09-30 | $-11.49M | (m) | (m) | $2.23M | (m) | (m) |
| 2016-06-30 | $-12.41M | (m) | (m) | $2.03M | (m) | (m) |
| 2016-03-31 | $-11.31M | (m) | (m) | $1.31M | (m) | (m) |
| 2015-12-31 | $-12.04M | (m) | (m) | $1.24M | (m) | (m) |
| 2015-09-30 | $-12.56M | (m) | (m) | $1.11M | (m) | (m) |
| 2015-06-30 | $-14.03M | (m) | (m) | $956.53K | (m) | (m) |
| 2015-03-31 | $-10.19M | (m) | (m) | $727.92K | (m) | (m) |
| 2014-12-31 | $-7.87M | (m) | (m) | $548.00K | (m) | (m) |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | $729.40K | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $-6.24M | (m) | (m) | $992.21K | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |